Authors: BANK S SNINSKY C ROBINSON M KATZ S SINGLETON J MINER P SAFDI M GALANDIUK S HANAUER S VARILEK G SANDS B BUCHMAN A ROGERS V SALZBERG B CAI B ROGGE H SCHWERTSCHLAG U

Citation: S. Bank et al., SAFETY AND ACTIVITY EVALUATION OF RHIL-11 IN SUBJECTS WITH ACTIVE CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 927-927

Authors: LEVINE DS PRUITT R RIFF D KOVAL G SALES D WRUBLE L REX D SALZBERG B MERRELL D BERRY W TORRES E KOGUT D RUBIN A YOUNG D JOHNSON LK

Citation: Ds. Levine et al., A MULTICENTER, DOUBLE-BLIND DOSE-RESPONSE TRIAL OF COLAZIDE(R) (BALSALAZIDE DISODIUM) AND ASACOL(R) (MESALAMINE) FOR MILD-MODERATELY ACTIVEULCERATIVE-COLITIS, Gastroenterology, 112(4), 1997, pp. 1026-1026

Authors: SALZBERG B

Citation: B. Salzberg, ON INDEXING SPATIAL AND TEMPORAL DATA, Information systems, 19(6), 1994, pp. 447-465

Authors: PEPPERCORN M DAS K ELSON C GERACI K ROBINSON M RUBIN A SALZBERG B WRUBLE L DUBE L ROUNTREE L BROUTMAN L

Citation: M. Peppercorn et al., ZILEUTON, A 5-LIPOXYGENASE INHIBITOR, IN THE TREATMENT OF ACTIVE ULCERATIVE-COLITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Gastroenterology, 106(4), 1994, pp. 10000751-10000751